In compliance with section 17(b) of the Securities Act, we are disclosing that Atai Life Sciences N.V. (NASDAQ: ATAI) is a client of TraDigital Marketing Group, Inc. Atai Life Sciences N.V. has an agreement in place, dated March 7, 2023 – December 21, 2023 to compensate TraDigital Marketing Group, Inc. as follows: three hundred sixty seven thousand five hundred dollars ($367,500) for a marketing budget, plus a retainer fee of 20% of the Marketing Cost Spent which equals seventy-three thousand five hundred dollars ($73,500), for publicly disseminating information about Atai Life Sciences N.V. via website, email, and SMS. 

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.